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Abstract: Capacity building in health research generally,
and helminthiasis research particularly, is pivotal to the
implementation of the research and development agenda
for the control and elimination of human helminthiases
that has been proposed thematically in the preceding
reviews of this collection. Since helminth infections affect
human populations particularly in marginalised and low-
income regions of the world, they belong to the group of
poverty-related infectious diseases, and their alleviation
through research, policy, and practice is a sine qua non
condition for the achievement of the United Nations
Millennium Development Goals. Current efforts support-
ing research capacity building specifically for the control
of helminthiases have been devised and funded, almost in
their entirety, by international donor agencies, major
funding bodies, and academic institutions from the
developed world, contributing to the creation of (not
always equitable) North–South ‘‘partnerships’’. There is an
urgent need to shift this paradigm in disease-endemic
countries (DECs) by refocusing political will, and harness-
ing unshakeable commitment by the countries’ govern-
ments, towards health research and capacity building
policies to ensure long-term investment in combating and
sustaining the control and eventual elimination of
infectious diseases of poverty. The Disease Reference
Group on Helminth Infections (DRG4), established in 2009
by the Special Programme for Research and Training in
Tropical Diseases (TDR), was given the mandate to review
helminthiases research and identify research priorities and
gaps. This paper discusses the challenges confronting
capacity building for parasitic disease research in DECs,
describes current capacity building strategies with partic-
ular reference to neglected tropical diseases and human
helminthiases, and outlines recommendations to redress
the balance of alliances and partnerships for health
research between the developed countries of the ‘‘North’’
and the developing countries of the ‘‘South’’. We argue
that investing in South–South collaborative research
policies and capacity is as important as their North–South
counterparts and is essential for scaled-up and improved
control of helminthic diseases and ultimately for regional
elimination.
Introduction
During their deliberations, and in the previous reports of this
collection [1–7], the members of the Disease Reference Group on
Helminth Infections (DRG4)—established in 2009 by the Special
Programme for Research and Training in Tropical Diseases
(TDR)—identified research gaps and priorities relevant to their
thematic areas and contributed to the setting of a research agenda
for the control and eventual elimination of human helminthiases.
However, the group soon realised that the setting of a research
agenda, although useful for advocacy and funding purposes, would
not, by itself, fully contribute to the alleviation of the problem of
helminthiasis [2]. The establishment and strengthening of research
capacity in disease-endemic countries (DECs) are absolutely
essential to make the control and elimination of these infections
truly achievable and sustainable in the long-term. In the context of
this paper, DECs are countries endemic for poverty-related
infectious diseases in general and helminthiases in particular.
Consequently, the issues concerning capacity building and
research policies in DECs received the special attention of the
DRG4 group after the Rio de Janeiro meeting in October 2010
[1]. In this paper, we focus on the research and development needs
of these important aspects, especially in the context of Africa. We
argue that investing in South–South collaborative research policies
and capacity is as important as their North–South counterparts
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and is essential for scaled-up and improved control of helminthic
diseases and ultimately for regional elimination.
Inequalities in Research Capacity
Building research capacity is a long-term process that requires a
systemic and inter-sectoral approach to developing appropriate
regulatory frameworks (including the establishment of institutional
review boards for ethical clearance of research proposals and
research governance), building and maintaining physical infra-
structure, and investing in human resources, equipment, and
training in an environment conducive to research commitment
and institutional support [8]. Above all, it requires demand and
supply for enhanced scientific research, based on a conviction that
research, and particularly health research, can improve the lives of
people and spur economic development. In this paper, health
research refers to an umbrella term encompassing research in
biomedical, epidemiological, public health, social science, and
environmental (among others) disciplines related to human health.
The level of infectious and parasitic disease research capacity
varies greatly across the world, and significant disparities exist in
research and technological expertise and facilities between
developed and developing countries. Substantial heterogeneity
also exists within the latter—in Africa, for instance, South Africa
(classified as ‘‘scientifically proficient’’), and Benin, Egypt, and
Mauritius (‘‘scientifically developing’’) have done reasonably well
regarding national investment and productivity in science and
technology, with the remaining countries in the continent falling
behind (‘‘scientifically lagging countries’’) [9]. Inequalities in
health research contribute to inequalities in health and ultimately
wealth. Some countries, such as Brazil and the People’s Republic
of China, have made remarkable progress, in part because their
governments have invested substantially in health research and
capacity building. For science to deliver its promise of improving
health and enabling development, all countries should be able to
participate equitably in research [8].
Inter-country differences are mainly due to major investments
that have been made by the developed world towards research and
development (R&D) activities, especially in the proportion of the
gross domestic product (GDP) that the countries’ governments are
willing to invest in research for an expected return. In some
developed countries, long-term investment has resulted in
extensive infrastructure, existence of national expertise and
national and international academic prestige, a tradition in
research funding, and a more expeditious path between basic
and clinical, translational research and its implementation into
public health policy and practice. Investments in research and
innovative technologies have tremendously improved health in the
developed world because of these countries’ clear health research
policies, including the setting up of priorities at institutional,
national, and regional levels. The readily available and opportune
deployment of such resources has led to rapid advances in
controlling infectious agents that have epidemic potential.
However, in the developing world, and especially in most African
countries, adequate investments by most DECs in research
capacity building to support prevention, control, and elimination
of infectious diseases of poverty are insufficient. In addition to the
paucity of highly trained researchers, there is a considerable brain
drain of the already scarce numbers of trained professionals,
fragmentation of research with much duplication of efforts, and a
lack of focus on distinct national needs. According to Chauhan
[10], lack of encouragement, unethical research practices that
have left a legacy of mistrust, a colonial past that has left some
degree of suspicion and engendered dependency, and most
importantly, an environment of political, social, and economic
instability, have all contributed to the scarcity of scientific research
in Africa. Whatever the reasons, the dearth of research conducted
in Africa for Africa is untenable [8] and threatens the long-term
sustainability of any disease control programme.
The purpose of this review is to examine the level of capacity
building in DECs, highlight some of the challenges that hinder the
development of health research capacity with particular reference
to poverty-related infectious diseases, summarise (not exhaustively)
available research capacity building initiatives and policies and
their implications for helminthiasis research and control, and
provide recommendations for improvement of research capacity
building towards the control and elimination of human helmin-
thiases. Box 1 lists the abbreviations used in this paper, and Box 2
presents five salient points for capacity building in helminthiasis
research.
Health Policy and Research Capacity in Disease-
Endemic Countries and Calls for Action
Research must focus on national priorities and high disease
burden conditions in DECs, with emphasis on evaluating
interventions that aim to strengthen research capacity and health
systems, and activities that translate knowledge into action and
benefits to the local population [8]. In many countries of sub-
Saharan Africa, Asia, Latin America, and the Caribbean,
neglected tropical diseases (NTDs) in general, and helminthiasis
and polyparasitism in particular, inflict a high disease burden [1–
3,5,11]. Adequate research capacity for the management of
helminthiases and other infectious diseases of poverty, including
the NTDs, forms an essential component of the tools needed to
meet the Millennium Development Goals (MDGs) [1]. Of
particular importance is the demonstration of a measurable
impact on health, educational success, and economic develop-
ment, which are essential to convince government officials that
financial investment in control programmes generates a tangible,
cost-effective return [12].
To achieve the MDGs, several recent high-level meetings on
research capacity and policy have called for action on health
research (Mexico City in November 2004 [13], Abuja in May
2006, Accra in June 2006 [14], and Bamako in November 2008
[15]). From the statements made and undersigned in these
meetings, it is clear that African governments have recognised the
importance of adopting sound policies on health research and the
potential positive implications such policies may have on the
health and development of their nations. The policy issues on
health research at both national and regional levels aimed at
developing and strengthening adequate national health research
policies and strategic frameworks based on national health
research and knowledge systems, as well as strengthening existing,
or creating novel South–South and South–North cooperation
partnerships, including technology transfer and research capacity
building [15]. In the Bamako Call to Action on Research for
Health (2008) held by ministers and representatives of ministries of
health, science and technology, education, foreign affairs, and
international cooperation from 53 countries, the focus was on
developing and strengthening policies on health research and
innovation for health, and development of equity at national and
regional levels [15]. All stakeholders were urged to ‘‘promote and
share the discovery and development of, and access to, products
and technologies addressing neglected and emerging diseases
which disproportionately affect low- and middle-income coun-
tries’’. Another important theme that ran through these meetings
was the need for financial investment in health research by all
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African governments, including a pledge for the allocation of at
least 2% of national health expenditure, and at least 5% of
external aid, for health projects and programmes into research and
research capacity building [16]. However, a clear commitment to
meet the resolutions deriving from such meetings has not yet been
made by all participating nations, particularly those of sub-
Saharan Africa. In addition, it was recognised that ‘‘the nature of
research and innovation for health improvement, especially in the
context of the United Nations Millennium Development Goals, is
not sufficiently inter-disciplinary and inter-sectoral; there is a need
to mobilize all relevant sectors (public, private, civil society) to
work together in effective and equitable partnerships to find
needed solutions’’.
It is, in our opinion, important that developing countries,
supported by developed countries and donors, establish internally
competitive national, or regional, research support and training
agencies that can prioritise areas of national (regional) interest for
potential support, be transparent and conduct open competitions
for the best projects, scientifically and in terms of potential impact,
have the possibility for a level of sustainability, integrate research
and training, and help leverage external funding to support the
national and regional efforts in research and training.
It is evident that more interaction among nations with similar
health problems and common infectious diseases is essential to
facilitate exchange of experiences as well as training of individuals
to help achieve the MDGs. This requires a great deal of
investment from both international and national funding bodies
to develop the facilities and the capabilities of scientists who can
drive research aimed at developing more effective tools and
strategies to fight infectious diseases of poverty. Improving
prevention and control strategies for NTDs will result in poverty
alleviation and consequent achievement of the MDGs. However,
this will require a sincere commitment, a governmental political
resolve, and competitive and transparent mechanisms to use
health research as a driver towards sustainable human resource
development, economic growth, and poverty reduction. Collabo-
rative research is surely one of the best means for strengthening
such research capacity, and in general, it has been the case that
scientists in DECs welcome collaboration with the more
industrialised nations of the North as a vehicle for overcoming
barriers to conducting research, obtaining training and funding,
and promoting the exchange of ideas. Unfortunately, scientists of
DECs seem less enthusiastic about collaboration between
countries within their own continents and regions [8]. In part,
this is because research funding opportunities for such South–
South collaboration have been limited (but see below for a number
of recent Brazil–Africa initiatives).
It is also true that most efforts towards health research and
NTD capacity building in DECs have been made with the impulse
of institutions based in industrialised countries. One of the major
international organisations that has played an important role in
building research capacity is the Special Programme for Research
Box 1. List of Abbreviations
ACBF, African Capacity Building Foundation
APOC, African Programme for Onchocerciasis Control
AusAID, Australian Agency for International Development
BioMalPar, Biology and Pathology of Malaria Parasite
Network
B&MGF, Bill and Melinda Gates Foundation
CAPES, Brazilian Federal Agency for the Support and
Evaluation of Graduate Education
CDTI, Community-Directed Treatment with Ivermectin
CGMRC, Centre of Geographical Medicine Research Coast
CNPq, National Research Council of Brazil
CSRS, Swiss Centre for Scientific Research, Coˆte d’Ivoire
DBL, Danish Bilaharziasis Laboratory-Institute for Health
Research and Development
DEC, disease-endemic country
DFID, Department for International Development, United
Kingdom
DIMACS/MBI, Center for Discrete Mathematics and Theo-
retical Computer Science/US–African Biomathematics Initia-
tive
DRG4, Disease Reference Group on Helminth Infections
EFINTD, European Foundation Initiative for African Re-
search into Neglected Tropical Diseases
FIOCRUZ, Oswaldo Cruz Foundation
GDP, gross domestic product
HKI, Helen Keller International
ICEMR, International Center of Excellence for Malaria
Research
IDRC, International Development Research Centre, Canada
IRD, Institut de Recherche pour le De´veloppement, France
JAF, Joint Action Forum (APOC)
JICA, Japan International Cooperation Agency
KEMRI, Kenya Medical Research Institute
KFPE, Commission for Research Partnerships with Develop-
ing Countries, Switzerland
KNUST, Kwame Nkrumah University of Science and
Technology, Ghana
MDG, Millennium Development Goal
M&E, monitoring and evaluation
MRC, Medical Research Council, United Kingdom
NGDO, non-governmental development organisation
NTD, neglected tropical disease
OCP, Onchocerciasis Control Programme in West Africa
PDP, product development partnership
RAPLOA, rapid assessment procedure for loiasis
R&D, research and development
REA, rapid epidemiological assessment
REMO, rapid epidemiological mapping of onchocerciasis
RNSA, Regional Network for Schistosomiasis in Africa
RNAS+, Regional Network for Asian Schistosomiasis and
other Zoonotic Helminths
SCI, Schistosomiasis Control Initiative
SCORE, Schistosomiasis Consortium for Operational Re-
search and Evaluation
SPHD, Section of Parasitology, Health and Development (of
former DBL)
STH, soil-transmitted helminthiasis
Swiss TPH, Swiss Tropical and Public Health Institute
TB, tuberculosis
TDR, Special Programme for Research and Training in
Tropical Diseases
TWAS, The Academy of Sciences for the Developing World
UNICEF, United Nations Children’s Fund (formerly United
Nations International Children’s Emergency Fund)
UNDP, United Nations Development Programme
USAID, United States Agency for International Development
VBD, vector-borne disease
WHO, World Health Organization
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and Training in Tropical Diseases (TDR), based at the World
Health Organization (WHO). The TDR has over the past 30 years
sponsored the training of graduates from DECs at both master’s
and doctorate levels, notwithstanding specialist technological
training, and further support (in the form of re-entry grants) to
return to their own countries and establish productive research.
The emphasis is on developing the research, management, and
leadership capacities of DEC scientists and fostering research
environments for long-term sustainability, quality processes, and
strategic partnerships (http://apps.who.int/tdr/svc/grants/calls/
grants-dec-investigators-2010). More recently, in 2010, the TDR
has sponsored research and training exchanges between African
scientists from Niger, Nigeria, and Uganda and the National
Institute of Parasitic Diseases, Chinese Center for Disease Control
and Prevention in Shanghai regarding schistosomiasis control.
This has resulted in a fruitful South–South connection between
two previously separate TDR-supported networks in schistosomi-
asis, namely, the Regional Network for Asian Schistosomiasis and
other Zoonotic Helminths (RNAS+, http://www.rnas.org.cn) and
the Regional Network for Schistosomiasis in Africa (RNSA,
http://www.rnsa.org.zm). Through this newly cemented collabo-
ration, the two networks can learn from one another to build their
capacity and expertise (http://www.who.int/tdr/publications/
documents/tdrnews86.pdf). Another significant step in the right
direction is the proposed relocation to Africa of the TDR-
supported Initiative to Strengthen Health Research Capacity in
Africa (ISHReCA), at present based at TDR/WHO in Geneva,
and sponsored by the Wellcome Trust, among other funders
(http://ishreca.org/).
In 2009, the Wellcome Trust funded the African Institutions
Initiative, aiming to develop institutional capacity to support and
conduct health-related research vital to enhancing people’s health,
lives, and livelihoods through the formation of seven new
international and pan-African consortia (Figure 1), with each
partnership being led by an African institution (http://
www.wellcome.ac.uk/News/Media-office/Press-releases/2009/
WTX055742.htm). This is in addition to longer-established
African-based programmes such as the KEMRI-Wellcome Trust
Research Programme at the Centre of Geographical Medicine
Research Coast (CGMRC), in Kilifi, Kenya (http://www.kemri-
wellcome.org/). There are many other such programmes, and
Table S1 lists some examples of current capacity building initiatives
in the area of health research and NTDs, particularly in Africa, with
external support. The African Capacity Building Foundation
(ACBF), though not focused on health, aims at building sustainable
human and institutional capacity for poverty reduction in Africa.
Since its inception in 1991, the ACBF has supported a total of 246
programmes and projects in some 44 sub-Saharan African countries
and committed more than US$400 million to capacity building
(http://www.acbf-pact.org/).
Regarding South–South initiatives, Brazil has, since 2008,
supported collaboration and training of African scientists through
the Pro-Africa Program for Thematic Cooperation in Science and
Technology of the National Research Council (CNPq, http://
www.cnpq.br). This scheme funds meetings, research, and seed
money to evaluate potential on collaborative efforts. In partnership
with the Academy of Sciences for the Developing World (TWAS,
http://www.twas.org/), an autonomous international organisation
based in Italy that promotes scientific capacity and excellence for
sustainable development in the South, CNPq also supports
students from African countries to be trained in Brazil at post-
graduate and post-doctoral levels. Furthermore, the Oswaldo Cruz
Foundation (FIOCRUZ), with support from the Brazilian
government, recently established an initiative with the Mozambi-
can National Institute of Health to create a master’s programme in
health sciences, with the goal of providing qualified human
resources for health research and innovation for Mozambique
[17]. For a more comprehensive account of Brazil’s conception of
South–South cooperation in health, the reader is referred to [18].
Challenges for Research Capacity Building in
Disease-Endemic Countries
As mentioned in the introductory paper of this collection [1],
R&D investment in the areas of NTDs in general, and
helminthiases in particular, pales into insignificance [11] in
comparison to that made for HIV/AIDS, malaria, and tubercu-
losis (TB) according to the G-FINDER reports of 2009 and 2010
Box 2. Summary Points for Capacity Building
in Helminthiasis Research
N There is great disparity in research capacity for parasitic
diseases between the developed countries of the North
and the developing countries of the South as well as
among, and within, the latter. Inequalities in health
research1 contribute to inequalities in health and
ultimately wealth. These inequalities are even more
pronounced in the case of infectious diseases of poverty
and helminthiases
N There have been a number of high-level meetings on
research for health in disease-endemic countries (DECs){,
with the Bamako Call to Action 2008 concluding that to
remedy the above, a greater proportion of the countries’
GDP should be invested in science and technology and
at least 2% of the ministries of health’s budgets should
be invested in research and research capacity
N Those countries of the South (e.g., Brazil, People’s
Republic of China, Cuba, India) that have invested
substantially in biomedical research and research and
development (R&D) have greatly increased their scien-
tific output, halted or reversed brain drain, and excelled
at product development partnerships and innovation
(e.g., diagnostics, reagents, drugs, vaccines)
N Capacity building is a long-term, systemic, and inter-
sectoral process, of which training of scientists is only a
component. A more comprehensive approach requires
physical infrastructure, appropriate equipment, condu-
cive research environment, regulatory frameworks in-
cluding the establishment of ethical review boards,
attractive pay and working conditions, and substantial
government support, including a competitive national
research funding agency and monetary investment
N There are a number of international initiatives aiming to
strengthen capacity building and establish interdisciplin-
ary and multinational teams addressing infectious
diseases of poverty in general and neglected tropical
diseases (NTDs) and helminthiases in particular. Nearly all
are funded by industrialised nations, accentuating
North–South alignment. Although these initiatives are
very welcome, they remain somewhat unbalanced
1An umbrella term referring in this paper to research in
biomedical, public health, social science, and environmen-
tal (among others) disciplines related to human health.
{In the context of this paper, DECs are countries endemic
for poverty-related infectious diseases, including HIV,
tuberculosis, malaria, and emerging, zoonotic, and ne-
glected tropical diseases.
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[19,20]. It is, therefore, not surprising, given the overall shrinking
levels of R&D investment made on helminthiases by industrialised
nations [11], that in most DECs, research on NTDs and
helminthiases is not considered a priority, receiving very little
attention and being further hindered by some of the obstacles
described below.
Outflow of Trained Staff
The science and health sectors in Africa, and to a lesser extent
Latin America and parts of Asia, suffer from a continuous outward
drain of trained staff, a problem that donors have addressed
primarily by financing training. But training is only part of the
solution to building human capacity, because low salaries, poor
and unattractive working conditions and environments, and lack
of institutional incentives to allow the development of the
individuals’ full scientific potential in their own countries also
contribute to low morale and high outflow. Technical assistance
and training have often proved ineffective in helping to build
sustained capacity. What is needed is a comprehensive approach
to human resource management as well as a systemic approach to
capacity building [21], including recognition of the importance of
developing a strong research culture in DECs.
Lack of Governmental Support
A report commissioned by the World Bank showed that with the
exception of South Africa and Egypt and a few others, most DECs
Figure 1. Countries and consortia in the African Institutions Initiative of The Wellcome Trust. (Redrawn from http://www.wellcome.ac.
uk/news/2009/features/wtx055738.htm.)
doi:10.1371/journal.pntd.0001602.g001
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in Africa (and also in Latin America, with the exception of Brazil
and Cuba, and Asia, excepting the People’s Republic of China and
India) incur very low national investments in research in general,
and have a low productivity in science and technology [9]. This
generalisation probably masks the fact that scientifically less
advanced countries may have reasonable capacity in certain areas,
but there is no doubt that the situation of health research in Africa
is dire [8]. Another World Bank report [21] found that most
capacity support remains fragmented, that the countries do not
fully ‘‘own’’ the capacity building agenda, and that the challenges
of capacity building vary across sectors within countries as well as
across countries. Research capacity building requires the invest-
ment of meaningful amounts of funds, which many of the DEC
governments are not willing to make because research is
considered a long-term undertaking that only rich countries can
afford, and because of other perceived pressing needs. Govern-
ments are inclined to follow agendas demanded by powerful, well-
organised lobby interests more readily than those sought by
seemingly weaker or more diffuse, decentralised interests, such as
investment in education and health [21]. There is a lack of
sufficient funds from the individual governments of DECs to
support institutional infrastructure, to fund medium- and long-
term research projects, and to create well-remunerated job
opportunities for local scientists. Moreover, these are major factors
preventing African scholars trained abroad from returning to their
home countries to pursue careers in health research. Despite these
small national inputs, research capacity development has been
identified as an important endeavour that should be fostered in
order to obtain the evidence-based knowledge that is relevant to
the health concerns of local communities and that policy-makers
can use for implementation of adequate practices [22].
Underdeveloped Collaborations and Networks
Establishing and nurturing collaborations in research is undoubt-
edly one of the best vehicles for building and strengthening research
capacity in DECs, and emphasis should be placed on long-term
partnerships. Efforts to incorporate as co-workers multinational
members of interdisciplinary teams can be of immense value, which
should be encouraged and cultivated [10]. Regrettably, the
collaborative links between the North and the South are stronger
than those between South and South, probably because it is perceived
that countries in the North can bring resources and technologies not
available in the South. Feeble South–South networking prevents
exchange of expertise between countries affected by the same
infections and often sharing the same transmission zones, and
imperceptibly contributes to the drain of the best researchers in the
South towards the North. There is a need to strengthen South–South
collaborations and to fund and establish research networks that
support, for example, technology transfer aimed at the development
and manufacturing of new diagnostic tools and anthelmintics for the
management and control of helminthiases.
Funding Issues and Ownership of Programmes
Most research capacity building efforts within and between
DECs are supported entirely by external donor agencies, research
funding bodies and foundations, pharmaceutical companies, and
non-governmental development organisations (NGDOs) such as
the World Bank (http://www.worldbank.org/); the Bill & Melinda
Gates Foundation (B&MGF, http://www.gatesfoundation.org/);
the Carter Center (http://www.cartercenter.org/index.html);
Fogarty International Center (http://www.fic.nih.gov/); Glaxo-
SmithKline (http://www.gsk.com/); Helen Keller International
(HKI, http://www.hki.org/); the Japan International Cooperation
Agency (JICA, http://www.jica.go.jp/; see Figure S1) and others
mentioned in Table S1 and below. For instance, the B&MGF,
through a five-year grant to the University of Georgia Research
Foundation, is funding the Schistosomiasis Consortium for
Operational Research and Evaluation (SCORE), established in
December 2008 to answer strategic questions about schistosomi-
asis control and elimination (http://score.uga.edu/). The chal-
lenge is how to ensure that low-income countries create a stable
demand for sustainable control, anthelmintic distribution, and the
research that supports these activities. In responding to this
demand, it is crucial that there is an appropriate supply of trained
personnel at various levels, and that the countries are able to raise
adequate resources to complement or eventually replace what is
already received from external sources, thus sustaining the success
of control and elimination efforts made once donor fatigue occurs,
or donor funding is diverted somewhere else. An excellent
example of such a transition from external donor funding to
internal, DEC funding is the African Programme for Onchocer-
ciasis Control (APOC). APOC is funded entirely from voluntary
contributions channeled through the APOC Trust Fund, and has
fostered North–South, North–South–South, and South–South
partnerships (Box 3 and Figure 2).
Basic and Operations Research and Specialised Training
The successes achieved by control programmes, like the former
Onchocerciasis Control Programme in West Africa (OCP), the
current APOC, and the Schistosomiasis Control Initiative (SCI),
have been partly realised because of the fundamental and
operations research carried out within the umbrella of the
programmes activities [1]. In most DECs, there is moderate
capacity for research in the areas of epidemiology, parasitology,
malacology, and entomology, but research capacity is lacking or
dwindling in some other specialised areas that are essential to
support successful control measures, such as transmission dynam-
ics modelling (see DIMACS/MBI in Table S1), advanced
statistical analysis of helminth and NTD epidemiological data,
parasite population biology and genetics, vector ecology, and
expertise for detection and monitoring of resistance to anti-
parasitic drugs and anti-vectorial measures. Expertise in these
areas and evidence-based research output are essential for
supporting appropriate decisions by policy-makers in the context
of implementation and evaluation over time of single and/or
integrated helminth control programmes [6,11]. In this context,
authors of this paper (MYO-A, RKP, M-GB) recently organised
and taught a course, funded by the Leverhulme–Royal Society
Africa Award (Table S1), on ‘‘Epidemiology, Transmission
Dynamics and Control of Vector-Borne (VBDs) and Neglected
Tropical Diseases (NTDs)’’ at the University of Ghana, including
topics on anthelmintic resistance, vector biology, infectious disease
modelling, and NTD epidemiology and control.
Insufficient Mentorship
In many DECs, scientists and/or lecturers from research
institutions and universities work mainly as individuals rather
than as teams. This leaves the new entrant, the young scientist/
lecturer, in a place where there is little or no guidance, direction,
or an environment that will facilitate his/her career development
and progression. Moreover, facilities and inputs for scientific
research available to the young scientist are limited. To facilitate
research capacity in DECs, there is a need for senior scientists/
faculty staff members at higher levels to mentor junior researchers.
Having a mentor with expertise, peer esteem, and networking skills
provides an invaluable triad function: guidance and direction for
the development of a career pathway; research facilities,
laboratories, and group support for practical experience; and
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access to a network of contacts for projection in the national and
international arenas. Mentors and role models provide not only
exposure to robust and demanding academic and research
environments and a vision of what is expected and possible to
achieve, but also opportunities to participate and present in
international conferences, and obtain feedback on research
dissemination activities, manuscripts, oral presentations, and grant
preparation. The introduction of the junior fellowships by the
European Foundation Initiative for African Research into
Neglected Tropical Diseases (EFINTDs) (Table S1) is a step in
the right direction, as young scientists will receive mentorship from
experienced scientists both from strong research institutions in the
North and in the South. This should help raise a generation of
young scientists with the required expertise to themselves serve as
mentors for the next generation. Mentorship programmes are
crucial in DECs, since unlike the institutions of the developed
nations, most DECs do not have the period of post-doctoral
internship and further training that new PhD graduates often have
access to in the North. It will be very helpful to DECs if
international funding agencies were able to provide more
fellowships with mentorship options for promising junior scientists,
just after completing their PhDs, and who are willing to remain in
or return to their home countries to build their own career with
the intention of focusing in their country’s research needs [23].
Access to Literature and Unedited Databases
Strict open-access publication policies, subsidies by the research
funders of wealthier nations, and the growth of prestigious and
high impact open-access journals (for instance in the Public
Library of Science and BioMed Central families) have ameliorated
the access of scientists in DECs to high quality and updated peer-
reviewed research. In particular, BioMed Central has recently
launched ‘‘Open Access Africa’’, a collection of initiatives designed
to increase the output and visibility of scientific research published
by African learning institutes. The Kwame Nkrumah University of
Science and Technology (KNUST) in Kumasi, Ghana, is the first
African Foundation Member to participate in BioMed Central’s
free membership scheme (http://www.biomedcentral.com/
developingcountries/events/openaccessafrica). However, a con-
siderable amount of investment by higher education and research
institutions is needed to maintain the necessary funding for
electronic journals, digitised archives, bibliographic databases, and
printed literature that are not easily available in DECs.
Furthermore, fast and reliable Internet access is sometimes lacking
in DECs, which in turn limits the access of researchers in those
countries to open-access information via the Internet. For a
compilation of web-based bibliography databases of epidemiology,
parasitology, and tropical medicine resources from the Spanish-
speaking Latin America and Caribbean regions, see [24]. Without
affiliation to a strong library in an academic institution, individual
Internet access even at broadband speed is not sufficient. This
hampers research and research capacity. As a positive example,
the Brazilian Federal Agency for the Support and Evaluation of
Graduate Education (CAPES) subscribes to all major peer-review
journals, a remarkable effort to make scientific publications
available to all academic and educational institutions in Brazil.
In addition, CAPES works with the Cambridge Overseas Trust to
offer the CAPES Cambridge Scholarship, which welcomed its first
recipients (Brazilian nationals) for PhD training in October 2011
(http://www.cambridgetrusts.org/partners/capes-brazil.html).
The issue of open access to helminth epidemiology databases for
the purposes of mathematical modelling is more fully discussed in
[6]. This ongoing issue has been an important hurdle in
developing collaborative programmes and has been addressed in
the preparatory meetings for the Bamako Call to Action [25].
While several institutions would like to have all data collected from
countries where diseases of the poor are prevalent placed on open-
access databases, this proposal has not had general acceptance
because it appears to give countries with highly structured,
efficient institutions, access to data at apparently no cost, which
have been generated, at great cost, by low- and middle-income
countries. The analysis of these data should be conducted and
shared between the latter before it is open to the former, or
password-protected access could be granted after mutually
beneficial agreements or memoranda of understanding for joint
analysis and publication of hard-earned data have been signed by
participant institutions and researchers [25]. There are also
intellectual property issues needing further discussion [26,27].
Box 3. Research Capacity and the African
Programme for Onchocerciasis Control
The World Bank is the fiscal agent of the African Programme
for Onchocerciasis Control (APOC); it manages the APOC
Trust Fund and reports annually to the Joint Action Forum
(JAF) on the financial situation of APOC. Community-directed
treatment with ivermectin (CDTI) activities are funded
through three mechanisms: trust funds available through
APOC, contributions from the national governments of
APOC countries, and funds from non-governmental devel-
opment organisations (NGDOs). To extend APOC activities
until 2015, US$60 million were raised during the JAF meeting
in Brussels in December 2007, when in celebration of the
20th anniversary of the donation of Mectizan (ivermectin),
the manufacturer and donor of the drug, Merck & Co., Inc.,
also became a financial donor of APOC.
Over 80% of funds are spent on technical and operational
activities in endemic countries. Figure 2 shows how
spending will decrease from 2008 to 2015, when APOC’s
mandate was intended to end. By this time, it is planned
that funding for sustained CDTI will be provided fully by the
governments and NGDOs of the participating countries,
completing the transition from external to internal funding
(http://www.who.int/apoc/about/funding/en/index.html).
Not only are the treatment activities of CDTI financed
through this mechanism, but also APOC provides funds to
encourage operations research and enable evaluation of
its impact by multidisciplinary and international teams
with a strong cadre of African scientists. Examples are the
studies for the feasibility of elimination through insecti-
cidal larviciding of the Bioko form of Simulium yahense,
which have led to the elimination of this vector species on
the Bioko island of Equatorial Guinea [47], and quantifica-
tion of the impact of CDTI on skin disease [48].
APOC is an example of North–South support being
extended to South–South cooperation. APOC and TDR
have supported relevant operations research in the areas of
rapid epidemiological mapping of onchocerciasis (REMO),
rapid epidemiological assessment (REA) of onchocerciasis,
rapid assessment procedure for loiasis (RAPLOA), and CDTI
as a community-empowering strategy. All this has contrib-
uted significantly to improved capability and increased
number of researchers in onchocerciasis-endemic countries
of Africa. APOC has supported research in the onchocerci-
asis-endemic countries either financially (Figure 2) or by
making high-level research experts from DECs or from other
countries available as mentors for local researchers.
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Investment in data collection and curation can be substantial, and
there has been little mutual collaboration between the developed
countries of the North using data from developing countries of the
South. It is clear that capacity building for data analysis and
translation of findings for improving health, together with new
research questions to be addressed, need further discussion. A
system needs to be developed where different stakeholders will
participate and share findings [25].
Lack of Advanced Enabling Technology Tools
DECs face challenges in research capacity for helminthiases and
other infectious diseases, especially in areas that require the
application of advanced technology for disease control such as
functional genomics and bioinformatics research. This may be
either due to the lack of trained personnel in such specialised areas,
the lack of appropriate infrastructure and equipment, or the brain
drain of the few local scientists and health professionals who may
have such expertise. Research capacity building in DECs faces the
greatest challenge in areas requiring the application of advanced
technologies such as genetics for disease control, genomics,
functional genomics (and other ‘‘omics’’), bioinformatics, and
computational biology that can, in the medium and long term,
have a major impact on disease control or elimination [28,29].
There is a lack of expertise in DECs for the development of new
reagents, products and approaches for diagnosis, anthelmintics,
vaccines, and integrated vector control, which are crucial for the
sustained success of current programmes for the control and
elimination of helminthiases [30]. If DECs had the adequate
research capacity for the development of effective functional
genomics tools and bioinformatics, areas like the study of gene
function could be applied for the development of novel drugs
based, for instance, on locally available natural products (see the
LANBIO and ANDI initiatives described in Text S1).
The path forward is not impossible, however. Some DECs in
South America, the Caribbean, and the African regions, despite
similar challenges, have been able to develop adequate research
capacity. For example, Brazil, Cuba, and South Africa have made
major technological advancements in the field of functional
genomics, bioinformatics, and vaccine development. Notably,
the scientific output and impact of these countries’ researchers
have increased internationally, and consequently the brain drain
has been reduced or halted [31]. Such progress is mostly due to the
financial investments made by the governments of such countries
to build and support adequate research capacity in their national
institutions. This is now yielding expertise in new technologies,
leading to the development of innovative interventions and
effective management of various diseases, with resultant progress
in infectious disease control. For instance, the first effective
meningitis B vaccine was developed at the Cuban Finlay Institute
(http://www.finlay.sld.cu/english/eindex.htm), and was recently
licensed to GlaxoSmithKline [32]. The FIOCRUZ/Bio-Man-
guinhos and Butantan Institutes of Brazil and other collaborative
institutions are full members in the product development
partnerships (PDPs) for the Human Hookworm Vaccine Initiative
[33]. The People’s Republic of China is one of the world’s leading
producers of penicillin, and together with India and Brazil,
Figure 2. African Programme for Onchocerciasis Control Trust Fund annual expenditure. Since the inception of APOC in 1995, expenditure
has increased steadily until 2007, mainly with external donor support (listed in http://www.who.int/apoc/about/funding/en/index.html). The orange and
dark turquoise portion of the bars represents investment in administration, and the grey and light turquoise portions indicate support for technical
activities, operations research, and capacity building. External funding has decreased since 2007 and it is anticipated that from 2015 onwards the
programme will be fully devolved to participating countries and their NGDOs. Recently, APOC’s mandate has been extended to 2025.
doi:10.1371/journal.pntd.0001602.g002
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produces praziquantel for schistosomiasis treatment. The National
Institute of Parasitic Diseases, Chinese Center for Disease Control
and Prevention in Shanghai, following a collaborative effort
between Chinese, European, and African scientists, has investi-
gated the effects of artemether, singly or in combination with
praziquentel, against the major human schistosome species [34].
The Serum Institute of India is the world’s leading manufacturer
of diphtheria-pertussis-tetanus vaccine. Over 60% of the United
Nations Children Fund’s vaccine requirements for the Expanded
Programme on Immunization are met by Brazil, Cuba, India, and
Indonesia [35].
Scarce Evaluation of Capacity Building and Research
Partnership Coalitions
A further challenge hampering the effective development of
research capacity building is the lack of application of the same
rigorous monitoring and evaluation (M&E) practices to capacity
building work that are implemented in other areas, with most
activities lacking standard quality assurance processes at the design
stage, and not being routinely tracked, monitored, and evaluated
[21]. Scientific training and outputs could, for instance, be
measured in terms of abundance and quality of research
dissemination activities; numbers of peer-reviewed papers pub-
lished by authors from DECs; number of grants in which the
principal investigator and research instigator are based in DECs;
number of trainees at undergraduate and post-graduate levels who
receive education in DECs or return to their home countries to
pursue health research careers; and number and impact of courses,
workshops, internships, or academic visits hosted or organised in
DECs, among others. Sustainability outputs could be assessed in
terms of having created a demand for sustainable parasite control
and for trained, local personnel to conduct and supervise it as well
as a corresponding supply and retention of such personnel; impact
of research findings on policy and practice, and in terms of the
countries’ capacity to assume ownership of and co-finance control
programmes implementation and M&E [23,36].
National, Regional, and Global Efforts and
Strategies towards Capacity Building for Research
in Infectious Diseases of Poverty
North–South Partnerships
Given the lack of political will and financial commitment by
most DECs to support research capacity building, the role of
global and regional efforts has become crucial in supporting and
sustaining the control of helminth infections. These efforts include
various established research partnerships between the developed
countries and the developing nations. Establishing these North–
South partnerships in the form of consortia, networks, and
collaborations between research institutions has made valuable
contributions to research capacity and should be encouraged,
although this requires significant financial investments [31,37,38].
These partnerships are essential for the training of skilled
personnel in research methods and dissemination, the translation
of the results of research into tangible actions, products, or
improved practices and policies for the benefit of communities and
individuals [31,39,40], and the deployment of current interven-
tions or the development of novel strategies within national,
regional, and global control programmes [38]. Text S1 describes
examples of such partnerships for the research and control of
helminthiases, the investigation of infectious diseases of poverty,
poverty elimination, and environmental sustainability (see also
Figure S1). For a more comprehensive and general account of
international initiatives for building research capacity in the South,
the reader is referred to [41].
For such partnerships to work effectively, they should include
major players such as local research institutions, universities, and
researchers on infectious diseases of poverty, managers of control
programmes, and policy-makers. They should also provide a
forum for an active involvement of the DECs and their scientists to
ensure that the priority needs of these countries, as well as the
training of local human resources, are met. For a more
comprehensive account of ‘‘desirables’’ in establishing ‘‘win-win’’
partnerships between the North and the South, readers are
referred to the ‘‘11 Principles for Research in Partnership with
Developing Countries’’ prepared and published by the Swiss
Commission for Research Partnerships with Developing Countries
(KFPE) [42], and more recently extended to 12 principles [43,44].
Bonfoh et al. [40] discuss how the application of these principles,
and the evolution of the partnerships from a very basic field
station, driven by external projects, to a fully fleshed research
centre, partnered with other African institutions, have ensured that
research at the Swiss Centre for Scientific Research (CSRS) in
Coˆte d’Ivoire has survived a decade of serious civil unrest.
Malaria research initiatives are good examples of such
integrated successes. Although it is a large and highly competitive
field, a number of networks exist to foster collaboration,
communication, and interactions not only amongst international
members, but also among local members. An example is the
Biology and Pathology of Malaria Parasite (BioMalPar), a network
of excellence funded by the European Commission, which has
been successful in establishing and strengthening malaria com-
munities and laboratories in both Europe and malaria-endemic
countries [45]. A more recent example, described in Text S1, is
the creation of International Centers of Excellence for Malaria
Research (ICEMR), which has established a global network of
independent research centres in malaria-endemic settings to
provide knowledge, tools, and evidence-based strategies to support
researchers working in a variety of endemic areas, especially
within governments and health care institutions.
South–South Partnerships
In addition to these North–South partnerships, research
capacity building can be reinforced by facilitating and providing
more opportunities for South–South collaborations [17,18]. Text
S1 also describes some of these initiatives. For instance, in the
Latin American and Caribbean region, Brazil and Cuba have
made major research investments resulting in a calibre of research
expertise and research institutions that are recognised interna-
tionally [18,32]. These well-established institutions could play a
major role as regional and inter-continental focal points for South–
South collaborations and capacity strengthening for other endemic
countries such as the Brazil–Africa programmes previously
described [17,18]. In Africa, only a few countries, such as South
Africa, have developed sound fiscal policies supporting knowledge-
based development and leading to wealth creation. This has
enabled them to invest in science and technology, build substantial
research capacity [9], and importantly, to provide attractive
remuneration packages to keep their scientists and other expertise
in the country. With such expertise and infrastructure, South
Africa could also serve as a regional focal point for South–South
collaborations within Africa and between other DECs.
Since such partnerships involve considerable financial commit-
ment, extended and continued support will still be needed from
global and regional donors, including the WHO, TDR, and other
major agencies, schemes, research and development institutions,
and funding bodies committed to capacity building such as the
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Health Programme of the European Commission (http://ec.
europa.eu/health/programme/funding_schemes/index_en.htm);
the training and capacity building programmes of the Section for
Parasitology, Health and Development (SPHD, http://www.ivs.
life.ku.dk/English/Sections/SPHD.aspx) of the former Danish
Bilharziasis Laboratory (DBL–Centre for Health Research and
Development), and of the former Swiss Tropical Institute (now
Swiss Tropical and Public Health Institute [Swiss TPH)] in Basel,
http://www.swisstph.ch/); the US Agency for International
Development (USAID, http://www.usaid.gov/), and in particular
the USAID’s Neglected Tropical Disease Program (http://www.
neglecteddiseases.gov/index.html); the Neglected and Other
Infectious Diseases Program of the B&MGF (http://www.
gatesfoundation.org/topics/Pages/neglected-diseases.aspx); the
New York-based Ford Foundation International Fellowships
Program (http://www.fordifp.net/); the International Develop-
ment Research Centre of Canada (IDRC, http://www.idrc.ca);
AusAID (http://www.ausaid.gov.au/) in Australia; the Institut de
Recherche pour le De´veloppement (IRD, http://www.ird.fr/) in
France; the Department for International Development of the
United Kingdom (DFID, http://www.dfid.gov.uk/); the Well-
come Trust (http://www.wellcome.ac.uk/), and the Medical
Research Council (MRC, http://www.mrc.ac.uk/index.htm) also
in the UK, as well as other foundations, initiatives, and
programmes (such as those listed in Table S1, summarised in
Text S1, and described in [41], which also provide awards to
support candidates from DECs for post-graduate studies at
master’s and doctoral levels, post-doctoral careers, and research
projects). However, these funding opportunities are highly
competitive, and therefore for nationals of DECs to access such
funds, local scientists should establish strong networks and
collaborations and also strengthen their publication and propos-
al-writing skills to enable them to tap into such opportunities for
research capacity building [23].
An important need to be addressed by both North–South and
South–South partnerships is that of improving the graduate-level
training for students in DECs. Unfortunately, the NTD knowledge
base in DECs is often not extensive and the investigators who are
involved in intervention programmes are usually associated with
ministries of health rather than with national universities.
Although this still would entail a great deal of involvement by
partners from the North, if external universities could provide
support for investigators to provide in-country training within
DECs to build up a critical mass of able personnel, the ability to
carry out and evaluate NTD control without relying on external
direction will one day become a reality. Often, for good training,
DEC students must travel elsewhere, which contributes to the exit
of qualified scientists who stay in their country of training rather
than returning to their home countries (but see Text S1 and Table
S1 for examples of current initiatives aiming to remedy this very
problem).
Concluding Remarks and Recommendations
Support for and from DECs for building relevant, DEC-led
research capacity for the control and elimination of human
helminthiases and infectious diseases of poverty is still inadequate
despite the many initiatives that exist, as these initiatives mainly
focus on research portfolios, researcher profiles, and administra-
tive requirements of the developed world [23,46]. Thus, a large
proportion of the funding for building research capacity in DECs
has tended to originate from donor agencies, funding bodies, and
research institutions whose epicentre is not located in DECs, and
whose principal investigators and research leaders represent the
interests of academic centres from the North rather than those
from the South. There is a vast disparity in the capacity to conduct
world-class research between the nations of the North and the less
developed countries of the South, partly based on a lack of
understanding of the potential for scientific research in general,
and health-associated research in particular to give the countries’
economies and development the necessary knowledge base to
break out of the poverty cycle. However, this potential will not be
realised if research does not translate into policies, actions, and
products destined to improve the situation of the afflicted
populations and break the cycle of poverty and deprivation that
the NTDs inflict on the most marginalised populations of the
world. This requires a concerted effort by the DECs and the many
national, regional, and global initiatives towards the development
of true, win-win partnerships. This would be a welcome path
towards meeting the MDGs.
In addition to the dearth of capacity in operations research and
appropriate, low-cost technologies to support the implementation
and, importantly, the M&E of helminthiases control programmes
by DECs, these countries also face challenges in areas that require
the application of advanced technology tools for disease control
such as genetics methods for the control of parasites and their
vectors, functional genomics, bioinformatics, computational biol-
ogy, and the development of new and optimised products for
diagnosis, treatment, and prophylaxis. This technological gap
further accentuates the chasm between the North and the South
and contributes to deepen the sense of dependency and inferiority
that prevents the DECs from fully assuming the responsibility of
tackling their pressing health needs and owning the intervention
programmes. Other areas of importance for the confident
development of research, which is appropriate and flexible in
light of ongoing interventions, is the lack of training in
transmission dynamics, epidemiological modelling [6], the prompt
and opportune detection of resistance to anti-parasitic drugs and
anti-vectorial products [3], and the economic evaluation of
interventions for demonstrating their cost-effectiveness [12] to
the scientific, donor, and political communities. Some policies on
health research and capacity building have already been
developed and implemented at both national and regional levels
in the Africa, Asia, Latin America and the Caribbean, and the
Pacific island regions. However, more concerted efforts are
required to ensure that the gaps in research capacity, commitment,
and R&D investment become narrower rather than wider in the
current climate of global financial instability and constraint [20].
Policies supporting the development of effective and truly
collaborative linkages and partnerships with international health
research agencies are in place and are necessary to augment
regional health research capability. Regional commitment and
strong advocacy are required to strengthen policies on health
research programmes aimed to provide evidence to justify health
actions and practice. As much as these policies are required, they
nonetheless have to be flexible and responsive to the short- and
long-term national needs. Cooperation and active interaction
among countries, not only in North–South alignments but also,
and importantly, in South–South alliances and other possible
configurations, will facilitate the development of clear policies in
the countries and institutions that will enhance research capacity
building and networking towards equitable health development. In
this respect, African countries could put in place research-friendly
legislative reforms that will facilitate exchange of expertise and the
sharing of valuable epidemiological databases whilst ensuring
intellectual property rights protection [6,25–27]. Finally, strong
and long-standing advocacy is needed to encourage governments
and policy makers to extend more financial and political will
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towards the more diffuse and longer-term activities of scientific
and health research, instead of the agendas of powerful lobbies
and short-term economic targets. This would eventually lead to
DECs building their own capacity to develop their appropriate
enabling technologies and innovative products. Box 4 lists five
recommendations for improving capacity in health research in
general and helminth research in particular stemming from this
report.
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